Results 121 to 130 of about 11,960 (207)

Efficacy and Safety of Artesunate + Amodiaquine and Artemether + Lumefantrine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in Madagascar, 2020. [PDF]

Am J Trop Med Hyg
Harimanana A, Randriamiarinjatovo DNAL, Rakotomanga TA, Irinantenaina J, Moriarty LF, Laird V, Patel D, Abdallah RA, Zhiyong Z, Svigel SS, Kapesa L, Razafindrakoto J, Ralinoro F, Rason MA, Andriamananjara MN, Razanatsiorimalala S, Razafinjato C, Randrianarivelojosia M.   +17 more
europepmc   +1 more source

Efficacy of artemether-lumefantrine, dihydroartemisinin-piperaquine, and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso, 2020-2021. [PDF]

Malar J
Gansane A, Tarama C, Lingani M, Debe S, Tiendrebeogo F, Kinda R, Sagnon A, Ganou A, Rouamba T, Sombie S, Some H, Kiendrebeogo S, Bonko MA, Tougri G, Kompaore CS, Wiesner L, Eddis C, Horton B, Kennedy C, Bajic M, Pierre-Louis E, Kahn A, Rosillo S, Patel DS, McCaffery JN, Plucinski MM, Laird V, Ahmed J, Tinto H, Valea I, Moriarty LF.   +30 more
europepmc   +1 more source

Malaria recrudescence after artemether-lumefantrine treatment in travellers- a hospital-based observational study and literature review. [PDF]

Trop Dis Travel Med Vaccines
Schnyder JL, Bache BE, Hoogakker M, Van De Ruit M, Zonneveld R, Hermans SM, Stijnis C, Van Vugt M, Hänscheid T, Van Hest RM, Goorhuis A, de Jong HK, Grobusch MP.   +12 more
europepmc   +1 more source

Efficacy and safety of artemether-lumefantrine (AL) and artesunate-amodiaquine (ASAQ) for the treatment of uncomplicated Plasmodium falciparum malaria in Liberia, 2022-2023. [PDF]

Malar J
Koko VS, Skrip L, Kumeh O, Washington T, Diallo MO, Kafuko J, Inyang U, Ponce de León GF, Zhou Z, Laird VR, Zawolo J, Getahun B, Harmon-Gray WM, Plucinski M, Schultz JS.   +14 more
europepmc   +1 more source

The Effect of Artemether-Lumefantrine Combined with a Single Dose of Primaquine on Plasmodium falciparum Gametocyte Clearance and Post-Treatment Infectivity to Anopheles arabiensis. [PDF]

Trop Med Infect Dis
Minwuyelet A, Yewhalaw D, Petronio Petronio G, Di Marco R, Atenafu G.   +4 more
europepmc   +1 more source

Artemether-lumefantrine efficacy among adults on antiretroviral therapy in Malawi. [PDF]

Malar J, 2023
Nyangulu W, Mungwira RG, Divala TH, Nampota-Nkomba N, Nyirenda OM, Buchwald AG, Miller J, Earland DE, Adams M, Plowe CV, Taylor TE, Mallewa JE, van Oosterhout JJ, Parikh S, Laurens MB, Laufer MK, TSCQ Study Team.   +16 more
europepmc   +1 more source

Efficacy and safety of artemether-lumefantrine (AL) and artesunate-amodiaquine (ASAQ) for the treatment of uncomplicated Plasmodium falciparum malaria among children 6-59 months in three sentinel sites of Sierra Leone, 2021-2022. [PDF]

Malar J
Cavros I, Abanyie F, Kamara ARY, Chalobah F, Fofana N, Ahmed J, Larbi K, Kennedy C, Horton B, Bajic M, Richardson M, Matlock B, McCaffery J, Kanu S, Schnabel D, Labor TSA, Cash S, Plucinski M, Komeh JP, Sillah-Kanu M.   +19 more
europepmc   +1 more source

Recurrent Plasmodium falciparum Malaria in U.S. Travelers Treated with Artemether-Lumefantrine. [PDF]

Am J Trop Med Hyg
Sy H, Yadav S, Yangga P, Shaffer A, John A, Rogers W, Westblade L, Marrero Rolón R, Madison-Antenucci S, Thwe PM, Orner E, Murphy K, Maldarelli GA, Kirkman L, Daily JP.   +14 more
europepmc   +1 more source

A systematic review and meta-analysis of clinical trials comparing arterolane-piperaquine vs. artemether-lumefantrine for the treatment of uncomplicated falciparum malaria. [PDF]

J Postgrad Med
Mondal A, Basu A, Modak DC, Goswami RP.
europepmc   +1 more source

Artemether-lumefantrine versus pyronaridine-artesunate for the treatment of malaria in patients with mild to moderate COVID-19 in Kenya and Burkina Faso: a randomised open-label trial (MALCOV). [PDF]

EClinicalMedicine
Tangara B, Barsosio HC, Marlais T, Kabore JMT, Tiono AB, Otieno K, Wanjiku M, Achieng M, Onyango ED, Ondieki ED, Aura H, Odawo T, Allen DJ, Hannan L, Tetteh KK, Soulama I, Ouedraogo A, Serme SS, Soulama BI, Barry A, Badoum ES, Matthewman J, Brazal-Monzó H, Canizales J, Drabko A, Wu W, Kariuki S, Lesosky M, Sirima SB, Drakeley C, Ter Kuile FO.   +30 more
europepmc   +1 more source